The structure of dinklageine 1, monoterpene alkaloid of a new type has been determined by spectral analysis. Its absolute stereochemistry has been established by its synthesis using loganin 2 as starting material.
Modified iridoid glycosides as anti-implantation agents
作者:Anju P Misra、Vijayavitthal T Mathad、Kanwal Raj、Amiya P Bhaduri、Rashmi Tiwari、Anuradha Srivastava、P.K Mehrotra
DOI:10.1016/s0968-0896(01)00105-5
日期:2001.11
Structural modifications in iridoid glycosides and evaluation of their efficacy on adhering capability (in vitro) of immature hamster uterine epithelial cells to the substratum have been studied. Out of 31, eight compounds in vitro, five compounds in utero and two in vivo showed adhesion/implantation preventing activity, respectively. The results provide an indication for further exploration in the line of development of anti-adhesive agents. (C) 2001 Published by Elsevier Science Ltd.
Fungitoxic non-glycosidic iridoids from Alibertia macrophylla
作者:M.Claudia M. Young、Marcia R. Braga、Sonia M.C. Dietrich、Hugo E. Gottlieb、Ligia M.V. Trevisan、Vanderlan Da S. Bolzani
DOI:10.1016/0031-9422(92)83701-y
日期:1992.10
The aqueous alcohol extract of the leaves of Alibertia macrophylla afforded two epimeric pairs of iridoid aglycones and one of them showed high inhibitory activity against Aspergillus niger, Cladosporium sphaerospermum, C. cladosporioides and Colletotrichum gloesporioides. Three of the compounds are reported for the first time from natural sources. Their structures were established on the basis of spectroscopic studies, mainly through C-13 NMR analysis.
Compositions and methods for treatment of liver disease
申请人:Fong Harry
公开号:US20080319042A1
公开(公告)日:2008-12-25
The present invention comprises compositions and methods for the treatment of liver disease, particularly treatments for infection by HCV and/or HBV. The present invention comprises antiviral compositions comprising lamiridosin, derivatives of lamiridosin or iridoids that are effective in inhibiting one or more steps in the infection of cells by HCV or HBV. Methods for treating subjects, particularly humans, infected with HCV or HBV are provided.